Sign in
CompletedNo phase

Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App

Key facts

Who runs it
University of Rochester
Where
Rochester, United StatesSee the site
Trial code
Status
Completed
People taking part
152 people enrolled
Started
17 Jul 2023
Ended
31 Dec 2025
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • InBloom
  • ROSE
Record updated
9 February 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • 17-32 weeks pregnant
  • enrolled for prenatal care in one of the five identified practices
  • English speaking
  • able to use an app (audio/visual/dexterity)
  • have one or more of the following PPD risk factors: Medicaid eligible; anxiety (GAD-7 > 10) during pregnancy; mild to moderate depressive symptoms (PHQ-9 = 10-19); self-reported history of depression treatment; gestational diabetes; and/or young age (18-21 years)

Who cannot take part

  • demonstrate significant cognitive impairment
  • younger than age 18
  • patients with acute mental health needs
  • cannot communicate in English
  • are planning to place the child for adoption
  • PHQ-9 depression score > 19

Where in United States

  • University of Rochester Medical CenterRochester, United States

About the trial

What the trial wants to find out

A randomized trial of pregnant people at risk for postpartum depression comparing the InBloom app (n = 76) to ROSE (n = 76; weekly scheduled group), and two control groups. We will assess Depression at baseline and 1, 2 and 3 months, ROI at 3 months, Satisfaction at 1 and 3 months and Perceived Access at 1 and 3 months. Subject participation will last up to 8 months (minimum 17 weeks pregnant through 3 months postpartum).

The 4 groups in the trial

  • women receiving InBloom appTreatment being tested

    Treatment: InBloom

  • women receiving ROSE as usualExisting treatment, for comparison

    Treatment: ROSE

  • historical controls- no treatmentNo study treatment, for comparison

    We will capitalize on data from a large ROSE trial which consists of a demographically similar sample by comparing depression diagnosis outcomes for Inbloom and ROSE to the 96 participants in the care as usual group (an educational pamphlet on PPD).

  • electronic health record utilization dataNo study treatment, for comparison

    We will leverage EHR utilization data by retrospectively identifying 152 people from the same clinics who did not receive ROSE or InBloom and matched for eligibility criteria, demographics and PPD risk factors using propensity scores, and comparing their utilization to those in the ROSE and InBloom groups.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
InBloom App vs ROSE Outcomes and Mechanisms
Publications
Record updated
9 February 2026